G. Maayan et al. / Tetrahedron Letters 49 (2008) 335–338
337
Adv. Mater. 2006, 18, 1239–1250; (d) Ninghai, H.;
Katsuyuki, A.; Hiroshi, Y. Inorg. Chim. Acta 1998, 163,
105–113; (e) Yilmaz, V. T.; Yilmaz, F.; Topcu, Y.; Andac,
O.; Guven, K. J. Mol. Struct. 2001, 560, 9–13; (f) Leydet,
Y.; Bassani, D. M.; Jonusauskas, G.; McClenaghan, N. D.
J. Am. Chem. Soc. 2007, 129, 8688–8689; (g) La Dela, M.;
Grisolia, A.; Aiello, I.; Crispini, A.; Ghedini, M.; Belviso,
S.; Amati, M.; Lelj, F. Dalton Trans. 2004, 2424–2431; (h)
Wang, J.; Oyler, K. D.; Bernhard, S. Inorg. Chem. 2007,
46, 5700–5706.
confirmed by electrospray mass spectrometry and were
in agreement with the expected values (Table 1).
The study presented here establishes the compatibility of
terpyridine, phenanthroline and hydroxyquinoline
groups with the solid-phase synthesis of peptoid oligo-
mers. Furthermore, we demonstrate the feasibility of
incorporating these heterocyclic ligands in peptoids of
various lengths and sequences. The results establish
the opportunity for realizing peptoid metal complexes,
using late transition metal ions (e.g., Co and Cu) as a
starting point. The ability to place one or two monomers
incorporating metal coordinating centers at specific
positions in the context of a peptidomimetic scaffold will
be exploited to direct the formation of intermolecular or
intramolecular metal complexes. This may enable the
control of peptoid structure and will point the way to
the formation of peptoid podands, as well as foldamers
with unique secondary, tertiary, or quaternary struc-
tures. We have recently obtained metal complexes of
peptoids bearing such ligands, which are currently under
investigation in our laboratory.
6. For example: (a) Gilmartin, B. P.; Ohr, K.; McLaughlin,
R. L.; Koerner, R.; Williams, M. E. J. Am. Chem. Soc.
2005, 127, 9546–9555; (b) Nicoll, A. J.; Miller, D. J.;
Futterer, K.; Ravelli, R.; Allemann, R. K. J. Am. Chem.
Soc. 2006, 128, 9187–9193.
7. Andres, P. A.; Lunkwitz, R.; Pabst, G. R.; Bohn, K.;
Wouters, D.; Scmatloch, S.; Schubert, U. S. Eur. J. Org.
Chem. 2003, 3769–3776.
8. 40-Chloro-2,20:60,200-terpyridine (286 mg, 1 mmol) and
ethanolamine (100 ll, 1.1 mmol) were added to a stirred
suspension of powdered KOH (280 mg, 5 mmol) in
DMSO (5 ml) and stirred at 40 ꢁC for 2 h. The reaction
mixture was then added to 40 ml of methylene chloride
and washed with water (3·). The methylene chloride
solution was dried over Na2SO4 and the solvent was
removed. 2-(2,20:60,200-Terpyridine-40-yloxy) ethylamine
(286 mg, 0.97 mmol) was obtained as a light yellow solid
in 97% yield and used subsequently without further
purification. 1H NMR (400 MHz, CDCl3): d = 3.9 (t,
Acknowledgments
00
This work was supported by a National Science Foun-
dation CAREER Award (#0645361). We thank the
NCRR/NIH for a Research Facilities Improvement
Grant (C06RR-165720) at NYU. We gratefully
acknowledge Professor Michael Ward for his helpful
comments and for the support of this study through
the Molecular Design Institute.
2H, Ha), 4.8 (t, 2H, Hb), 7.25 (t, 2H, H5;5 ), 7.75 (t, 2H,
00
0
0
00
H4;4 ), 8.05 (s, 2H, H3 ;5 ), 8.55 (d, 2H, H3;3 ), 8.65 (d, 2H,
H6;6 ) ppm. 13C NMR (400 MHz, CDCl3): d = 40.9 (Ca),
00
00
00
00
77.1 (Cb), 107.4 (C5,5 ), 121.3 ðC4;4 Þ, 123.8 ðC3;3 Þ, 136.7
0
0
00
00
0
0
ðC3 ;5 Þ, 149.0 ðC6;6 Þ, 155.87 ðC2;2 Þ, 156.5 ðC2 ;6 Þ, 166.8
+
+
0
(C4 ) ppm. ESI-MS: m/z = 293.1 (M ), 315.2 (M+Na ).
9. 5-Chloro-1,10-phenanthroline (560 mg, 2.6 mmol) and
ethanolamine (175 ll, 2.9 mmol) were added to powder
KOH (730 mg, 13 mmol) in DMSO (10 ml) and stirred at
80 ꢁC for 6 h. The reaction mixture was then added to
100 ml of methylene chloride and washed with water (4·).
The methylene chloride solution was dried over Na2SO4
and the solvent was removed. The brown solid was
purified from warm methylene chloride (2·) and 2-(1,10-
phenanthroline-5-yloxy) ethylamine (442 mg, 1.85 mmol)
was obtained as a light brown solid in 71% yield and used
subsequently without further purification. 1H NMR d
(400 MHz, DMSO): d = 9.03 (dd, 2H, H2,9), 8.42 (dd, 2H,
References and notes
1. (a) Kirshenbaum, K.; Barron, A. E.; Goldsmith, R. A.;
Armand, P.; Bradley, E.; Truong, K.-T. V.; Dill, K. A.;
Cohen, R. E.; Zuckermann, R. N. Proc. Natl. Acad. Sci.
U.S.A. 1998, 95, 4303–4308; (b) Wu, C. W.; Sanborn, T.
J.; Zuckermann, R. N.; Barron, A. E. J. Am. Chem. Soc.
2001, 123, 2958–2963; (c) Wu, C. W.; Sanborn Huang, K.
T. J.; Zuckermann, R. N.; Barron, A. E. J. Am. Chem.
Soc. 2001, 123, 6778–6784; (d) Fafarman, A. T.; Borbat,
P. P.; Freed, J. H.; Kirshenbaum, K. Chem. Commun.
2007, 377–379; (e) Shin, S.-B. Y.; Yoo, B.; Todaro, L.;
Kirshenbaum, K. J. Am. Chem. Soc. 2007, 129, 3218–
3225.
2. Patch, J. A.; Kirshenbaum, K.; Seurynck, S. L.; Zucker-
mann, R. N.; Barron, A. E. Pseudo-Peptides Drug
Discovery 2004, 1–31.
3. (a) Zuckermann, R. N.; Kerr, J. M.; Kent, S. B. W.;
Moos, W. H. J. Am. Chem. Soc. 1992, 114, 10646–10647;
(b) Pei, Y. H.; Moos, W. H. Tetrahedron Lett. 1994, 35,
5825–5828; (c) Horn, T.; Lee, B. C.; Dill, K. A.;
Zuckermann, R. N. Bioconjugate Chem. 2004, 15, 428–
435.
H
4,7), 7.9 (s, 1H, H6), 7.7 (dd, 2H, H3,8) ppm. 13C NMR
(400 MHz, CDCl3): d = 40.0 (Ca), 79.5 (Cb), 123.3 (C3,8),
126.6 (C6), 129.1 (C6a), 130.8 (C4a), 136.2 (C4,7), 145.8 and
147.3 (C10a,b), 150.1 (C2,9) 151.4 (C5) ppm. ESI-MS:
m/z = 240.0 (M+), 262.1 (M+Na+).
10. 8-Hydroxy-2-quinolinecarbonitrile (1 g, 5.9 mmol) was
dissolved in acetic acid (43 ml). Pd/C (10%, 220 mg) was
added and the solution was treated with H2 (1 atm) for
14 h. The catalyst was filtered and the solvent was
removed. The crude product was re-crystallized from a
mixture of CHCl3 and Et2O. The light brown solid was
filtered, dissolved in CHCl3 (160 ml), and treated with a
1 M potassium bicarbonate solution (4 ml). The product
was extracted with CHCl3, dried over Na2SO4, and the
solvent was removed. 8-Hydroxy-2-quinolinemethylamine
(66 mg, 3.8 mmol) was obtained as a light brown solid in
65% yield and used subsequently without further purifi-
cation. 1H NMR (400 MHz, DMSO): d = 8.2 (d, 1H, H7),
7.5 (d, 1H, H2), 7.35 (dt, 2H, H5,6), 7.08 (dd, 1H, H3), 5.2
(br s, 2H, NH2), 4.03 (s, 2H, Ha) ppm. 13C NMR
(400 MHz, DMSO): d = 46.35 (Ca), 110.0 (C7), 116.4 (C5),
119.5 (C3), 125.7 (C6), 126.5 (C4a), 135.1 (C4), 136.4 (C8a),
4. Burkoth, T. S.; Fafarman, A. T.; Charych, D. H.;
Connolly, M. D.; Zuckermann, R. N. J. Am. Chem. Soc.
2003, 125, 8841–8845.
5. For example (a) Andres, P. A.; Schubert, U. S. Adv.
Mater. 2004, 16, 1043–1068; (b) Hofmeier, H.; Schubert,
U. S. Chem. Soc. Rev. 2004, 33, 373–399; (c) Bonnet, S.;
Collin, J.-P.; Koizumi, M.; Mobian, P.; Sauvage, J.-P.